Tsubota Laboratory Swings to Loss but Projects Sharp Rebound in 2027

Tsubota Laboratory Incorporated ( (JP:4890) ) has shared an update.

Tsubota Laboratory reported a sharp downturn in non-consolidated results for the fiscal year ended March 31, 2026, with revenue plunging 85.3% to ¥200 million and swinging from a prior-year profit to a net loss of ¥761 million. The company’s equity fell to ¥863 million and cash on hand declined to ¥969 million, reflecting heavy operating cash outflows and a more constrained financial position.

Despite the weak year, management forecasts a strong rebound for the year to March 2027, guiding revenue to ¥1.1 billion–¥1.5 billion and a return to profitability with net income of ¥45 million–¥90 million. The company plans no dividends, underscoring a priority on preserving capital and funding operations, and the ambitious recovery outlook highlights both significant upside potential and execution risk for shareholders.

More about Tsubota Laboratory Incorporated

Tsubota Laboratory Incorporated is a Japan-based company listed on the Tokyo Stock Exchange under code 4890. The firm operates in the life sciences sector, focusing on research-driven products and services, and remains in a growth and investment phase as indicated by its volatile revenues and ongoing operating losses.

Average Trading Volume: 705,355

Technical Sentiment Signal: Sell

Current Market Cap: Yen7.4B

See more insights into 4890 stock on TipRanks’ Stock Analysis page.